MedTrace Logo

Fecal Microbiota and Monocyte Trained Immunity in CHD Patients With Different hsCRP

NCT06562309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-08-20

No results posted yet for this study

Summary

This single-center study enrolled patients aged 35-75 years who were diagnosed with unstable angina (UA), and had at least one of the three major coronary arteries with a ≥ 50% reduction in lumen diameter by angiographic visual estimation. Patients were all recruited at the Department of Cardiology, Union Hospital, Wuhan, Hubei Province, China. Feces and blood samples were collected on admission were used promptly for ex vivo studies.

Conditions

Interventions

OTHER

take feces and blood samples from patients

this study does not involve any intervention

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Xiang Cheng · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-11
Primary Completion
2024-04-30
Completion
2024-07-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06562309 on ClinicalTrials.gov